Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Host factors in bacteremia.

K L Cates

    The American Journal of Medicine
    |July 28, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Host immune responses, including phagocytes, complement, immunoglobulin, and cell-mediated immunity, are crucial for fighting bacteremia. Modulating these defenses offers a promising strategy to improve patient survival rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    From scientific evidence to child health policy.

    Pediatric annals·1998
    Same author

    Interactions of C3 and C4 with Haemophilus influenzae.

    The Journal of infectious diseases·1992
    Same author

    C4B deficiency is not associated with meningitis or bacteremia with encapsulated bacteria.

    The Journal of infectious diseases·1992
    Same author

    Transient lymphoblastosis and thrombocytopenia in Gianotti-Crosti syndrome.

    Clinical pediatrics·1990
    Same author

    Longitudinal development of specific and functional antibody in very low birth weight premature infants.

    Pediatric research·1988
    Same author

    Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer.

    The Journal of pediatrics·1987
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric Panniculitis.

    The American journal of medicine·2026
    Same journal

    Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

    The American journal of medicine·2026
    See all related articles

    Area of Science:

    • Immunology
    • Infectious Diseases
    • Microbiology

    Background:

    • Host defense mechanisms against bacteremia involve both nonspecific (phagocytes, complement) and specific (immunoglobulin, cell-mediated immunity) immune responses.
    • These immune components function synergistically to eliminate bacteria from the bloodstream.
    • Despite advances in antibiotic therapy and supportive care, bacteremia continues to have significant morbidity and mortality rates.

    Purpose of the Study:

    • To review the host factors involved in combating bacteremia.
    • To highlight the potential of immunoprophylaxis and immunotherapy in managing serious bacterial infections.
    • To explore immune system modulation as a strategy for improving patient outcomes in bacteremia.

    Main Methods:

    • Literature review of host immune responses in bacteremia.

    Related Experiment Videos

  • Analysis of the roles of phagocytes, complement, immunoglobulin, and cell-mediated immunity.
  • Discussion of immunoprophylaxis, immunotherapy, and immune modulation strategies.
  • Main Results:

    • Nonspecific and specific immune responses are critical for host defense against bacteremia.
    • Immunoprophylaxis and immunotherapy leverage natural host defenses.
    • Immune system modulation shows promise for enhancing survival in bacteremia patients.

    Conclusions:

    • Understanding host immune factors is essential for combating bacteremia.
    • Therapeutic strategies targeting the immune system can improve patient prognosis.
    • Further research into immune modulation holds potential for reducing bacteremia-related mortality.